Keyphrases
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
81%
Emergency Department
71%
Heart Failure
68%
Acute Coronary Syndrome
60%
Pregnancy-associated Plasma protein-A (PAPP-A)
58%
Triage
57%
Myocardial Infarction
50%
Chronic Obstructive Pulmonary Disease
49%
Risk Stratification
47%
Troponin
47%
All-cause Mortality
45%
ST-elevation Myocardial Infarction (STEMI)
44%
Confidence Interval
38%
Systolic Heart Failure
34%
Short-term Mortality
33%
High-sensitivity Cardiac Troponin
29%
YKL-40
29%
Cluster Randomized Trial
29%
Left Ventricular Ejection Fraction
29%
High Risk
27%
Non-ST-segment Elevation Acute Coronary Syndrome (NSTE-ACS)
25%
Coronary Artery Disease
25%
Echocardiography
25%
Vulnerable Plaque
24%
Forced Expiratory Volume in 1 Second (FEV1)
24%
Consecutive Patients
24%
Exercise Capacity
24%
Overall Mortality
23%
Prognostic Biomarker
23%
Inflammatory Biomarkers
23%
Left Ventricular Function
23%
Hs-cTnT
23%
Stable Coronary Artery Disease
22%
Infective Endocarditis
22%
Cardiac Troponin
21%
Spirometry
21%
Copenhagen
21%
Strong Predictor
20%
Hemodialysis
20%
Triage Algorithm
19%
Lung Function
19%
Iron Deficiency
19%
Severe Aortic Stenosis
19%
Renal Disease
19%
Renal Impairment
19%
Retrospective Cohort Study
19%
Endocarditis
19%
Chest Pain
19%
Forced Vital Capacity
18%
Readmission
18%
Medicine and Dentistry
Congestive Heart Failure
100%
Emergency Department
70%
Urokinase Receptor
60%
Biological Marker
54%
Outpatient
43%
Triage
39%
Chronic Obstructive Pulmonary Disease
39%
Prevalence
37%
Risk Stratification
34%
Systolic Heart Failure
34%
Heart Left Ventricle Ejection Fraction
30%
Troponin T
29%
Placebo
28%
Echocardiography
28%
Lung
26%
Cardiac Magnetic Resonance Imaging
25%
Infective Endocarditis
25%
Coronary Artery Disease
24%
Heart Function
24%
Exercise
24%
Acute Coronary Syndrome
24%
All Cause Mortality
22%
Diseases
21%
Spirometry
20%
Aortic Stenosis
19%
Iron Deficiency
19%
Retrospective Cohort Study
19%
Cardiac Troponin
19%
Pregnancy-Associated Plasma Protein A
19%
Exercise Test
17%
Ejection Fraction
17%
ST Segment Elevation Myocardial Infarction
16%
Cohort Analysis
15%
Combination Therapy
15%
